SCHEMBL7308429

SCHEMBL7308429

CCN(C)C(=O)[C@H](CC(C)C)C(CN1C(=O)c2ccccc2C1=O)C(=O)NOCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 4/20 0.44
MMP3 P08254 3/20 0.44
MMP2 P08253 3/20 0.44
MMP8 P22894 2/20 0.44
MMP13 P45452 2/20 0.44
MMP9 P14780 4/20 0.44
MAPK1 P28482 1/20 0.40
GAA P10253 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 1/20 0.40
RAB9A P51151 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ELANE P08246 1/20 0.38
CTSL P07711 2/20 0.38
CTSB P07858 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7308423 1.00 MMP1 (0.44) MMP1MMP3MMP2MMP8MMP13
SCHEMBL7280170 0.84 MMP2 (0.60) MMP1MMP3MMP2MMP8MMP13
SCHEMBL7280160 0.84 MMP2 (0.60) MMP1MMP3MMP2MMP8MMP13
SCHEMBL7373620 0.72 MAPK1 (0.49) MMP1MMP3MMP2MMP8MMP13
SCHEMBL7373619 0.72 MAPK1 (0.49) MMP1MMP3MMP2MMP8MMP13
SCHEMBL7373763 0.72 MAPK1 (0.49) MMP1MMP3MMP2MMP8MMP13
SCHEMBL8601030 0.69 ECE1 (0.49) MMP1RAB9ACTSLCTSBCTSK
SCHEMBL9714088 0.69 CTSK (0.39) MMP1MMP2MMP9RAB9ACTSL
SCHEMBL7375195 0.68 MMP1 (0.46) MMP1MMP3MMP2MMP8MMP13
SCHEMBL7371909 0.68 MMP1 (0.46) MMP1MMP3MMP2MMP8MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0574758-B1 Hydroxamic acid derivatives as collagenase inhibitors HOFFMANN LA ROCHE (CH) 1998-09-09 EP disclosed
US-5318964-A Collangenase inhibitors; antiarthritic and -tumor agents; rheumatic diseases; osteoarthritis; atherosclerosis; multiple sclerosis HOFFMANN-LA ROCHE INC. (US) 1994-06-07 US disclosed
EP-0574758-A1 Hydroxamic acid derivatives as collagenase inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1993-12-22 EP disclosed